Abbisko Cayman Ltd

0
FRA:8ZD (China)  
€ 0.62 (+18.1%) Nov 8
At Loss
P/B:
1.34
Market Cap:
€ 366.73M ($ 390.69M)
Enterprise V:
€ 95.33M ($ 101.56M)
Volume:
48.05K
Avg Vol (2M):
16.01K
Trade In:
Volume:
48.05K
At Loss

Business Description

Description
Abbisko Cayman Ltd is an investment holding company that operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The company has only one business segment which is the development of innovative medicines.
Name Current Vs Industry Vs History
Cash-To-Debt 68.98
Equity-to-Asset 0.95
Debt-to-Equity 0.01
Debt-to-EBITDA 0.38
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 10.42
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 16.1
3-Year EPS without NRI Growth Rate 14.9
3-Year FCF Growth Rate -53.4
Name Current Vs Industry Vs History
5-Day RSI 88.23
9-Day RSI 82.96
14-Day RSI 78.85
6-1 Month Momentum % 11.29
12-1 Month Momentum % -3.72

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 21.75
Quick Ratio 21.75
Cash Ratio 21.09

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 2.7
Shareholder Yield % 2.3

Financials

FRA:8ZD's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Abbisko Cayman Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 63.678
EPS (TTM) (€) -0.004
Beta 0.5
Volatility % 48.48
14-Day RSI 78.85
14-Day ATR (€) 0.032145
20-Day SMA (€) 0.4505
12-1 Month Momentum % -3.72
52-Week Range (€) 0.236 - 0.62
Shares Outstanding (Mil) 625.26

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Abbisko Cayman Ltd Filings

Filing Date Document Date Form
No Filing Data

Abbisko Cayman Ltd Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Abbisko Cayman Ltd Frequently Asked Questions

What is Abbisko Cayman Ltd(FRA:8ZD)'s stock price today?
The current price of FRA:8ZD is €0.62. The 52 week high of FRA:8ZD is €0.62 and 52 week low is €0.24.
When is next earnings date of Abbisko Cayman Ltd(FRA:8ZD)?
The next earnings date of Abbisko Cayman Ltd(FRA:8ZD) is .
Does Abbisko Cayman Ltd(FRA:8ZD) pay dividends? If so, how much?
Abbisko Cayman Ltd(FRA:8ZD) does not pay dividend.

Press Release

Subject Date
No Press Release